Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

NCT03115853 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03115853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03115853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2009
Completion date
January 31, 2012
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high blood pressure